Edwards Lifesciences Reports Q3 EPS $1.07 Vs Est $0.98, Sales #615.5M Vs Est $598.29M; Sees Q3 Adj EPS $1.11-$1.21 Vs Est $1.14 & Revs $620M-$660M Vs Est $630.20M; Raises FY EPS To $4.43-$4.53 Vs Est $4.37